Cited by 114Gut microbiota and healthClostridium difficile and Clostridium perfringens researchGastrointestinal motility and disorders

Identification of clinical and ecological determinants of strain engraftment after fecal microbiota transplantation using metagenomics

Open access
Podlesny, Daniel, Durdevic, Marija, Paramsothy, Sudarshan, Kaakoush, Nadeem O., Högenauer, Christoph, Gorkiewicz, Gregor, Walter, Jens, Fricke, W. Florian·2022·Cell Reports Medicine

Published version of a preprint

Abstract

ABSTRACT Fecal microbiota transplantation (FMT) is both a promising therapeutic approach to treat microbiota-associated pathologies and an experimental tool to establish a causal role of microbiome dysbiosis in human pathologies. Although clearly efficacious in resolving recurrent Clostridioides difficile infection (rCDI), the therapeutic value of FMT in other pathologies is not yet established, and our mechanistic and ecological understanding of how FMT alters the microbiome in patients is incomplete. Here, we assembled the most comprehensive FMT trial microbiota dataset to date, including new and previously generated fecal metagenomes from FMT trials in rCDI, inflammatory bowel disease (IBD), metabolic syndrome (MetS), drug-resistant pathogen colonization (MDR), and resistance to immune checkpoint inhibitor anti-tumor therapy (ICI). We characterized post-FMT microbiota assembly in the recipients by establishing the origin of the detected strains, and we identified the clinical and ecological factors that determine the engraftment of donor strains. Our findings showed little coexistence of donor and recipient strains and linked the magnitude of donor strain engraftment to dysbiosis of the recipient microbiome. Dysbiosis and strain engraftment were low in pathologies other than rCDI but could be enhanced through pretreatment with antibiotics and lavage. Using generalized linear mixed-effects models, we demonstrate that both ecological (low recipient and high donor ɑ-diversity and relative species abundance) and clinical (antibiotic pretreatment, bowel lavage, multiple rounds of FMT) variables are associated with increased donor microbiota engraftment, and that donor strain engraftment events are predictable for individual patients and strains. Overall donor strain engraftment was not linked to FMT outcome in IBD patients but was higher in ICI patients that responded to immunotherapy after FMT. Our findings provide an ecological framework for post-FMT microbiota assembly that can predict donor strain engraftment and determine its importance for clinical outcomes, informing more targeted and personalized approaches to increase the therapeutic benefits of FMTs.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.xcrm.2022.100711

Cites

102 of 103 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the TURN trial, the post-FMT microbiome of recipients who experienced clinical success was more similar to the microbiome of their corresponding donors than to their microbiome before FMT, with a shift in beta diversity.

    “In the TURN trial, the post-FMT microbiome of recipients who experienced clinical success was more similar to the microbiome of their corresponding donors than to their microbiome before FMT, with a shift in their beta diversity. 60”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [4]Kao D. Roach B. Silva M. Beck P. Rioux K. Kaplan G.G. Chang H.-J. Coward S. Goodman K.J. Xu H. Effect of oral capsule– vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection JAMA 318 2017 1985 1993 29183074 PMC5820695

Cited by

Sorted by citations

Authors
Podlesny, D., Durdevic, M., Paramsothy, S., Kaakoush, N. O., Högenauer, C., Gorkiewicz, G., Walter, J., & Fricke, W. F.
Affiliations
  • University of Hohenheim (DE)
  • The University of Sydney (AU)
  • UNSW Sydney (AU)
  • Medical University of Graz (AT)
  • University College Cork (IE)
Corresponding author
  • Podlesny, Daniel
  • Fricke, W. Florian
Venue
Cell Reports Medicine
Publisher
Elsevier BV
Published
2022-08
Volume
3
Issue
8
Pages
100711
ISSN
2666-3791 (ISSN-L)
OpenAlex
W4289835872
Cited by
111
References
103
Citations by year
2026: 19 · 2025: 41 · 2024: 37 · 2023: 10 · 2022: 4
FWCI
7.76
Type
journal article
Language
en
Open access
Locations
  • Cell Reports Medicine (publishedVersion, cc-by)
  • medRxiv (acceptedVersion, cc-by-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • Deutsche Forschungsgemeinschaft (316130265)
  • Austrian Science Fund (DK-MOLIN W1241)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
fecal microbiota transplantation, microbiome assembly, dysbiosis, antibiotic pretreatment, alpha diversity, strain coexistence, oral microbiota, Gram-positive bacteria, oxygen tolerance
MeSH terms
Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Clostridium Infections, Humans, Metagenomics, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review